Suzanne Blaug
Director/Board Member presso FIBROGEN, INC.
Patrimonio netto: 69 546 $ in data 31/03/2024
Profilo
Suzanne Blaug is an Independent Director at FibroGen, Inc. She previously worked as Managing Director at Johnson & Johnson, SVP-Global Marketing & Commercial Development at Amgen, Inc., Head at Janssen Alzheimer Immunotherapy, Principal at EMEA Capital LLP, and Vice President-Europe Strategic Marketing at Janssen Global Services LLC.
Blaug holds an undergraduate degree from The University of North Carolina at Chapel Hill and an MBA from Kellogg School of Management.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
FIBROGEN, INC.
0.03% | 09/06/2023 | 29 594 ( 0.03% ) | 69 546 $ | 31/03/2024 |
Posizioni attive di Suzanne Blaug
| Società | Posizione | Inizio |
|---|---|---|
| FIBROGEN, INC. | Director/Board Member | 05/06/2019 |
Precedenti posizioni note di Suzanne Blaug
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Sales & Marketing | 01/08/2018 |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal | 01/03/2012 |
Janssen Global Services LLC
 Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Corporate Officer/Principal | 01/10/2009 |
EMEA Capital LLP
 EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Corporate Officer/Principal | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Formazione di Suzanne Blaug
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
| Janssen Alzheimer Immunotherapy | |
EMEA Capital LLP
EMEA Capital LLP Investment ManagersFinance EMEA Capital LLP is a privately-held investment management firm which was founded by Osman Semerci in 2008. Headquartered in London, the firm provides asset management services to individual and institutional clients. | Finance |
Janssen Global Services LLC
Janssen Global Services LLC Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Janssen Global Services LLC develops treatments for patients in therapeutic areas of healthcare. The private company is based in Raritan, NJ. | Health Technology |
- Borsa valori
- Insiders
- Suzanne Blaug
